For example, injection of IFN-β [29,31,33–35] or TGF-β inhibitor such as galunisertib [36–40] and LY2109761 [41,42] can be a novel anti-tumour strategy due to their effective tumour killing and anti-tumour immune response [43,44]. The gene discussed is TGFB1; the disease is neoplasm.